Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine

NCT06235606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: Bupivacaine Liposome 13.3 Milligrams/Milliliter [Exparel]
DRUG: Dexmedetomidine 0.5milligram (50micrograms)

Sponsor

The University of Hong Kong